Assessment of plasma endocan for the prediction of mortality in COVID-19 patients undergoing veno-venous ECMO: A pilot study

Med Intensiva. 2023 Jan;47(1):51-54. doi: 10.1016/j.medin.2022.04.003. Epub 2022 May 5.

C Levy^{1

2

3

4}, N Dognon^{1

2

3

4}, S Normandin^{1

2

3

4}, T Duburcq^{1

2

3

4}, A Gaudet^{1

2

3

5

4}; Lille Intensive Care COVID-19 group; Lille Intensive Care COVID-19 group; Erika Parmentier-Decrucq, Julien Poissy, Sylvain Dubucquoi, Pauline Boddaert, Morgan Caplan, Julien Goutay, Arthur Durand, Benoit Graffin, Myrtille Gaudel, Charles Detollenaere, Ines Gueguen, Marine Van Ceunebroek, Romain Tortuyaux, Ouriel Saura, Ahmed El Kalioubie, Raphael Favory, Patrick Girardie, Marion Houard, Emmanuelle Jaillette, Mercedes Jourdain, Geoffrey Ledoux, Daniel Mathieu, Anne Sophie Moreau, Saad Nseir, Thierry Onimus, Sebastien Preau, Laurent Robriquet, Anahita Rouze, Sophie Six, Jerome Soquet, Valentin Loobuyck, Agnes Mugnier, André Vincentelli

¹ Department of Intensive Care Medicine, Critical Care Center, CHU Lille, F-59000 Lille, France.
² University of Lille, U995-LIRIC-Lille Inflammation Research International Center, Lille, France.
³ CHU Lille, Immunology Institute, F-59000 Lille, France.
⁴ University Lille, Inserm, U1285, CNRS, UMR 8576 - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France.
⁵ University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR9017-CIIL-Centre d'Infection et d'Immunité de Lille, F-59000 Lille, France.

No abstract available

Publication types